International Journal of Immunogenetics · 1996 · 19 citations · 24 references
Life SciencesGeneticsImmunologyAutoimmunityImmunogeneticsImmunopathologyAutoimmune Disease Susceptibility GenesAutoimmune DiseasesDisease Susceptibility LociEosinophilic DisordersGenetic Susceptibility To AutoimmunityHla TypingHla Allele PolymorphismHla AllelesHla Autoimmune Disease AssociationsHla Class I MoleculesHla Class Ii MoleculesHla Genotype AssociationsHla ImmunogeneticsHla Risk Alleles
The cause of toxic oil syndrome (TOS) has not yet been definitively determined, but some genetic susceptibility factors (certain HLA antigens and female sex) have been identified in 236 patients. Similarities with genetic factors for scleroderma and hydralazine-induced lupus (i.e. in TOS female sex and HLA-A24, Pcorrected = 0.00001 and DR4, Pcorrected = 0.04, respectively) may provide a clue to the responsible xenobiotic and its pathogenesis, and may also help in understanding the basis of the related eosinophilia-myalgia syndrome associated with tryptophan ingestion. In this paper it is also established that a human class I antigen (HLA-A24) and, independently, an HLA class II haplotype (DR4-DQ8, Pcorrected = 0.04) and arginine 52 in the alpha-DQ chains (Pcorrected = 0.03) are associated with TOS susceptibility, similarly to insulin-dependent diabetes. This further supports the classification of TOS as an autoimmune disease. Also, the increased frequency of a particular set of low-frequency HLA class I antigens in chronic TOS patients (i.e. B27, B37, B38 and B49) and the probable decrease in the frequency of HLA-B homozygotes in surviving patients (Pcorrected = 0.008) may provide an objective model to explain the maintenance of the HLA polymorphism: less frequent HLA alleles may be more advantageous in the event of unexpected human contact with unusual xenobiotics (not only microbes); however, other mechanisms working together to preserve and generate HLA polymorphism may coexist.
24
HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY
J. R. Batchelor, K. I. Welsh, Roberto Tinoco et al. · The Lancet · 1980 · 387 citations
Nomenclature for factors of the HLA system, 1991
Julia G. Bodmer, Steven G. E. Marsh, E. D. Albert et al. · Tissue Antigens · 1992 · 339 citations · Full text
Dan Larhammar, L. Schenning, Kenth Gustafsson et al. · Proceedings of the National Academy of Sciences · 1982 · 322 citations · Full text
Nomenclature for Factors of the HLA System, 1991
Julia G. Bodmer, Steven G. E. Marsh, E. D. Albert et al. · Vox Sanguinis · 1992 · 289 citations